The global blepharoplasty market was valued at $3,454.64 million in 2021 and is projected to reach $7,202.67 million by 2031, registering a CAGR of 7.6% from 2022 to 2031. Blepharoplasty is a type of cosmetic surgery that is used to improve the appearance of the eyelids. The procedure involves removing excess skin, fat, and muscle from the upper and/or lower eyelids. The goal of the surgery is to reduce signs of aging, as well as improve vision by removing excess tissue that can interfere with peripheral vision. Blepharoplasty can also be used to correct droopiness of the eyelids.
The rise in awareness about blepharoplasty procedures and increase in adoption of this procedure among the elderly and young population for enhancing their facial appearance, drive the growth of the blepharoplasty market. For instance, according to the American Society of Plastic Surgeons (ASPS), there is a steady increase in the number of cosmetic procedures performed on individuals under the age of 18 in recent years. In 2020, the ASPS reported that there were approximately 208,000 cosmetic procedures performed on individuals under the age of 18, which represents a 2% increase as compared to 2019.In addition, rise in the technological advancement in blepharoplasty, rise in the cosmetics surgeries to remove wrinkles, excessive fats, and skin near the eyes and rise in the demand for non-invasive surgical procedures are the major factors that propels the growth of the market.
However, factors that may restrain the blepharoplasty market include the overall health of the patient. Patients with certain medical conditions, such as high blood pressure, diabetes, or heart disease, may not be suitable candidates for the procedure. Similarly, patients who smoke may be at a higher risk of complications and may not be preferred candidates for blepharoplasty which will further challenge the blepharoplasty market in the forecast period. On the other hand, the high cost of treatment and unavoidable side effects of the procedures are some factors that are anticipated to restrain the growth of the blepharoplasty market.
Moreover, rise in the demand from emerging economies and modernization in production techniques is expected to further create new opportunities for blepharoplasty market during the forecast period. Moreover, besides the demand for better appearance, blepharoplasty is generally used in patients who have experienced a trauma or disease that has caused them to lose upper eyelid due to cancer or injury and also increasing eye disorders in geriatric population such as dermatochalasis. Thus, these factors are expected to drive the growth of market.
The blepharoplasty market is segmented on the basis of type, gender, service provider, and region. On the basis of type, the market is segmented into upper eyelid surgery, lower eyelid surgery and combination eyelid surgery. On the basis gender, the market is divided into female and male. On the basis of service provider, the market is divided into hospital, clinics, and ambulatory surgical centers. On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
The major key players that operate in the global blepharoplasty market are Sisram Medical Ltd, AbbVie Inc, LightScalpel, Lumenis, Grand Aespio Inc., Medtronic plc, Surgical Holdings Ltd., Medline Industries, inc., London Bridge Plastic Surgery, M A Corporation.
The rise in awareness about blepharoplasty procedures and increase in adoption of this procedure among the elderly and young population for enhancing their facial appearance, drive the growth of the blepharoplasty market. For instance, according to the American Society of Plastic Surgeons (ASPS), there is a steady increase in the number of cosmetic procedures performed on individuals under the age of 18 in recent years. In 2020, the ASPS reported that there were approximately 208,000 cosmetic procedures performed on individuals under the age of 18, which represents a 2% increase as compared to 2019.In addition, rise in the technological advancement in blepharoplasty, rise in the cosmetics surgeries to remove wrinkles, excessive fats, and skin near the eyes and rise in the demand for non-invasive surgical procedures are the major factors that propels the growth of the market.
However, factors that may restrain the blepharoplasty market include the overall health of the patient. Patients with certain medical conditions, such as high blood pressure, diabetes, or heart disease, may not be suitable candidates for the procedure. Similarly, patients who smoke may be at a higher risk of complications and may not be preferred candidates for blepharoplasty which will further challenge the blepharoplasty market in the forecast period. On the other hand, the high cost of treatment and unavoidable side effects of the procedures are some factors that are anticipated to restrain the growth of the blepharoplasty market.
Moreover, rise in the demand from emerging economies and modernization in production techniques is expected to further create new opportunities for blepharoplasty market during the forecast period. Moreover, besides the demand for better appearance, blepharoplasty is generally used in patients who have experienced a trauma or disease that has caused them to lose upper eyelid due to cancer or injury and also increasing eye disorders in geriatric population such as dermatochalasis. Thus, these factors are expected to drive the growth of market.
The blepharoplasty market is segmented on the basis of type, gender, service provider, and region. On the basis of type, the market is segmented into upper eyelid surgery, lower eyelid surgery and combination eyelid surgery. On the basis gender, the market is divided into female and male. On the basis of service provider, the market is divided into hospital, clinics, and ambulatory surgical centers. On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
The major key players that operate in the global blepharoplasty market are Sisram Medical Ltd, AbbVie Inc, LightScalpel, Lumenis, Grand Aespio Inc., Medtronic plc, Surgical Holdings Ltd., Medline Industries, inc., London Bridge Plastic Surgery, M A Corporation.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the blepharoplasty market analysis from 2021 to 2031 to identify the prevailing blepharoplasty market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the blepharoplasty market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global blepharoplasty market trends, key players, market segments, application areas, and market growth Strategies.
Key Market Segments
By Gender
- Female
- Male
By Type
- Upper Eyelid Blepharoplasty
- Lower Eyelid Blepharoplasty
- Combination Eyelid Surgery
By Service Provider
- Hospitals
- Clinics
- Ambulatory Surgical Centre
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abbvie Inc
- LightScalpel
- Lumenis
- Medtronic plc
- Surgical Holdings Ltd.
- Medline industries, inc.
- Sisram Medical Ltd
- Grand Aespio Inc.
- London Bridge Plastic Surgery
- M A Corporation
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of vision impairment.
3.4.1.2. Rise in demand for non-invasive surgical procedures.
3.4.2. Restraints
3.4.2.1. High cost of blepharoplasty procedure
3.4.3. Opportunities
3.4.3.1. Increase in adoption of cosmetic procedures.
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: BLEPHAROPLASTY MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Upper Eyelid Blepharoplasty
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Lower Eyelid Blepharoplasty
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Combination Eyelid Surgery
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: BLEPHAROPLASTY MARKET, BY GENDER
5.1. Overview
5.1.1. Market size and forecast
5.2. Female
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Male
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: BLEPHAROPLASTY MARKET, BY SERVICE PROVIDER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Ambulatory Surgical Centre
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: BLEPHAROPLASTY MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Gender
7.2.4. Market size and forecast, by Service Provider
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Gender
7.2.5.1.4. Market size and forecast, by Service Provider
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Gender
7.2.5.2.4. Market size and forecast, by Service Provider
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Gender
7.2.5.3.4. Market size and forecast, by Service Provider
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Gender
7.3.4. Market size and forecast, by Service Provider
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Gender
7.3.5.1.4. Market size and forecast, by Service Provider
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Gender
7.3.5.2.4. Market size and forecast, by Service Provider
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Gender
7.3.5.3.4. Market size and forecast, by Service Provider
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Gender
7.3.5.4.4. Market size and forecast, by Service Provider
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Gender
7.3.5.5.4. Market size and forecast, by Service Provider
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Gender
7.3.5.6.4. Market size and forecast, by Service Provider
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Gender
7.4.4. Market size and forecast, by Service Provider
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Gender
7.4.5.1.4. Market size and forecast, by Service Provider
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Gender
7.4.5.2.4. Market size and forecast, by Service Provider
7.4.5.3. Australia
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Gender
7.4.5.3.4. Market size and forecast, by Service Provider
7.4.5.4. India
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Gender
7.4.5.4.4. Market size and forecast, by Service Provider
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Gender
7.4.5.5.4. Market size and forecast, by Service Provider
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Gender
7.4.5.6.4. Market size and forecast, by Service Provider
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Gender
7.5.4. Market size and forecast, by Service Provider
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Gender
7.5.5.1.4. Market size and forecast, by Service Provider
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Gender
7.5.5.2.4. Market size and forecast, by Service Provider
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Gender
7.5.5.3.4. Market size and forecast, by Service Provider
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Gender
7.5.5.4.4. Market size and forecast, by Service Provider
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Sisram Medical Ltd
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Abbvie Inc
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Grand Aespio Inc.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. LightScalpel
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Lumenis
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Medline industries, inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Medtronic plc
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Surgical Holdings Ltd.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. London Bridge Plastic Surgery
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. M A Corporation
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
List of Tables
Table 01. Global Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 02. Blepharoplasty Market for Upper Eyelid Blepharoplasty, by Region, 2021-2031 (Revenue, $Million)
Table 03. Blepharoplasty Market for Lower Eyelid Blepharoplasty, by Region, 2021-2031 (Revenue, $Million)
Table 04. Blepharoplasty Market for Combination Eyelid Surgery, by Region, 2021-2031 (Revenue, $Million)
Table 05. Global Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 06. Blepharoplasty Market for Female, by Region, 2021-2031 (Revenue, $Million)
Table 07. Blepharoplasty Market for Male, by Region, 2021-2031 (Revenue, $Million)
Table 08. Global Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 09. Blepharoplasty Market for Hospitals, by Region, 2021-2031 (Revenue, $Million)
Table 10. Blepharoplasty Market for Clinics, by Region, 2021-2031 (Revenue, $Million)
Table 11. Blepharoplasty Market for Ambulatory Surgical Centre, by Region, 2021-2031 (Revenue, $Million)
Table 12. Blepharoplasty Market, by Region, 2021-2031 (Revenue, $Million)
Table 13. North America Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 14. North America Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 15. North America Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 16. North America Blepharoplasty Market, by Country, 2021-2031 (Revenue, $Million)
Table 17. U.S. Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 18. U.S. Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 19. U.S. Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 20. Canada Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 21. Canada Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 22. Canada Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 23. Mexico Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 24. Mexico Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 25. Mexico Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 26. Europe Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 27. Europe Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 28. Europe Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 29. Europe Blepharoplasty Market, by Country, 2021-2031 (Revenue, $Million)
Table 30. Germany Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 31. Germany Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 32. Germany Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 33. France Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 34. France Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 35. France Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 36. UK Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 37. UK Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 38. UK Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 39. Italy Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 40. Italy Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 41. Italy Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 42. Spain Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 43. Spain Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 44. Spain Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 45. Rest of Europe Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 46. Rest of Europe Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 47. Rest of Europe Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 48. Asia-Pacific Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 49. Asia-Pacific Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 50. Asia-Pacific Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 51. Asia-Pacific Blepharoplasty Market, by Country, 2021-2031 (Revenue, $Million)
Table 52. Japan Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 53. Japan Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 54. Japan Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 55. China Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 56. China Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 57. China Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 58. Australia Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 59. Australia Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 60. Australia Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 61. India Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 62. India Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 63. India Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 64. South Korea Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 65. South Korea Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 66. South Korea Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 67. Rest of Asia-Pacific Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 68. Rest of Asia-Pacific Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 69. Rest of Asia-Pacific Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 70. LAMEA Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 71. LAMEA Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 72. LAMEA Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 73. LAMEA Blepharoplasty Market, by Country, 2021-2031 (Revenue, $Million)
Table 74. Brazil Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 75. Brazil Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 76. Brazil Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 77. Saudi Arabia Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 78. Saudi Arabia Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 79. Saudi Arabia Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 80. South Africa Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 81. South Africa Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 82. South Africa Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 83. Rest of LAMEA Blepharoplasty Market, by Type, 2021-2031 (Revenue, $Million)
Table 84. Rest of LAMEA Blepharoplasty Market, by Gender, 2021-2031 (Revenue, $Million)
Table 85. Rest of LAMEA Blepharoplasty Market, by Service Provider, 2021-2031 (Revenue, $Million)
Table 86. Sisram Medical Ltd.: Key Executives
Table 87. Sisram Medical Ltd.: Company Snapshot
Table 88. Sisram Medical Ltd.: Product Segments
Table 89. Sisram Medical Ltd.: Product Portfolio
Table 90. Abbvie Inc.: Key Executives
Table 91. Abbvie Inc.: Company Snapshot
Table 92. Abbvie Inc.: Product Segments
Table 93. Abbvie Inc.: Product Portfolio
Table 94. Abbvie Inc.: Key Strategies
Table 95. Grand Aespio Inc.: Key Executives
Table 96. Grand Aespio Inc.: Company Snapshot
Table 97. Grand Aespio Inc.: Product Segments
Table 98. Grand Aespio Inc.: Product Portfolio
Table 99. Lightscalpel: Key Executives
Table 100. Lightscalpel: Company Snapshot
Table 101. Lightscalpel: Product Segments
Table 102. Lightscalpel: Product Portfolio
Table 103. Lumenis: Key Executives
Table 104. Lumenis: Company Snapshot
Table 105. Lumenis: Product Segments
Table 106. Lumenis: Product Portfolio
Table 107. Medline Industries, Inc.: Key Executives
Table 108. Medline Industries, Inc.: Company Snapshot
Table 109. Medline Industries, Inc.: Product Segments
Table 110. Medline Industries, Inc.: Product Portfolio
Table 111. Medtronic PLC: Key Executives
Table 112. Medtronic PLC: Company Snapshot
Table 113. Medtronic PLC: Product Segments
Table 114. Medtronic PLC: Product Portfolio
Table 115. Surgical Holdings Ltd.: Key Executives
Table 116. Surgical Holdings Ltd.: Company Snapshot
Table 117. Surgical Holdings Ltd.: Product Segments
Table 118. Surgical Holdings Ltd.: Product Portfolio
Table 119. London Bridge Plastic Surgery: Key Executives
Table 120. London Bridge Plastic Surgery: Company Snapshot
Table 121. London Bridge Plastic Surgery: Product Segments
Table 122. London Bridge Plastic Surgery: Product Portfolio
Table 123. M a Corporation: Key Executives
Table 124. M a Corporation: Company Snapshot
Table 125. M a Corporation: Product Segments
Table 126. M a Corporation: Product Portfolio
List of Figures
Figure 01. Blepharoplasty Market, 2021-2031
Figure 02. Segmentation of Blepharoplasty Market, 2021-2031
Figure 03. Top Investment Pockets in Blepharoplasty Market (2022-2031)
Figure 04. Low Bargaining Power of Suppliers
Figure 05. Low Bargaining Power of Buyers
Figure 06. Low Threat of Substitutes
Figure 07. Low Threat of New Entrants
Figure 08. Low Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globalblepharoplasty Market
Figure 10. Blepharoplasty Market, by Type, 2021(%)
Figure 11. Comparative Share Analysis of Blepharoplasty Market for Upper Eyelid Blepharoplasty, by Country 2021-2031(%)
Figure 12. Comparative Share Analysis of Blepharoplasty Market for Lower Eyelid Blepharoplasty, by Country 2021-2031(%)
Figure 13. Comparative Share Analysis of Blepharoplasty Market for Combination Eyelid Surgery, by Country 2021-2031(%)
Figure 14. Blepharoplasty Market, by Gender, 2021(%)
Figure 15. Comparative Share Analysis of Blepharoplasty Market for Female, by Country 2021-2031(%)
Figure 16. Comparative Share Analysis of Blepharoplasty Market for Male, by Country 2021-2031(%)
Figure 17. Blepharoplasty Market, by Service Provider, 2021(%)
Figure 18. Comparative Share Analysis of Blepharoplasty Market for Hospitals, by Country 2021-2031(%)
Figure 19. Comparative Share Analysis of Blepharoplasty Market for Clinics, by Country 2021-2031(%)
Figure 20. Comparative Share Analysis of Blepharoplasty Market for Ambulatory Surgical Centre, by Country 2021-2031(%)
Figure 21. Blepharoplasty Market by Region, 2021
Figure 22. U.S. Blepharoplasty Market, 2021-2031 ($Million)
Figure 23. Canada Blepharoplasty Market, 2021-2031 ($Million)
Figure 24. Mexico Blepharoplasty Market, 2021-2031 ($Million)
Figure 25. Germany Blepharoplasty Market, 2021-2031 ($Million)
Figure 26. France Blepharoplasty Market, 2021-2031 ($Million)
Figure 27. UK Blepharoplasty Market, 2021-2031 ($Million)
Figure 28. Italy Blepharoplasty Market, 2021-2031 ($Million)
Figure 29. Spain Blepharoplasty Market, 2021-2031 ($Million)
Figure 30. Rest of Europe Blepharoplasty Market, 2021-2031 ($Million)
Figure 31. Japan Blepharoplasty Market, 2021-2031 ($Million)
Figure 32. China Blepharoplasty Market, 2021-2031 ($Million)
Figure 33. Australia Blepharoplasty Market, 2021-2031 ($Million)
Figure 34. India Blepharoplasty Market, 2021-2031 ($Million)
Figure 35. South Korea Blepharoplasty Market, 2021-2031 ($Million)
Figure 36. Rest of Asia-Pacific Blepharoplasty Market, 2021-2031 ($Million)
Figure 37. Brazil Blepharoplasty Market, 2021-2031 ($Million)
Figure 38. Saudi Arabia Blepharoplasty Market, 2021-2031 ($Million)
Figure 39. South Africa Blepharoplasty Market, 2021-2031 ($Million)
Figure 40. Rest of LAMEA Blepharoplasty Market, 2021-2031 ($Million)
Figure 41. Top Winning Strategies, by Year
Figure 42. Top Winning Strategies, by Development
Figure 43. Top Winning Strategies, by Company
Figure 44. Product Mapping of Top 10 Players
Figure 45. Competitive Dashboard
Figure 46. Competitive Heatmap: Blepharoplasty Market
Figure 47. Top Player Positioning, 2021
Figure 48. Sisram Medical Ltd.: Net Revenue, 2019-2021 ($Million)
Figure 49. Sisram Medical Ltd.: Revenue Share by Segment, 2021 (%)
Figure 50. Sisram Medical Ltd.: Revenue Share by Region, 2021 (%)
Figure 51. Abbvie Inc.: Net Revenue, 2019-2021 ($Million)
Figure 52. Abbvie Inc.: Revenue Share by Segment, 2021 (%)
Figure 53. Abbvie Inc.: Revenue Share by Region, 2021 (%)
Figure 54. Medtronic PLC: Net Sales, 2020-2022 ($Million)
Figure 55. Medtronic PLC: Revenue Share by Segment, 2022 (%)
Figure 56. Medtronic PLC: Revenue Share by Region, 2022 (%)
Executive Summary
According to the report titled, 'Blepharoplasty Market,' the blepharoplasty market was valued at $3,454.64 million in 2021 and is estimated to reach $7,202.67 million by 2031, exhibiting a CAGR of 7.6% from 2022 to 2031. Blepharoplasty or eyelid surgery, is a surgical procedure to improve the appearance of the eyelids. Surgery can be performed on the upper lids, lower lids or both. To remove excessive skin and fine wrinkles from the eyelids. Eye bag surgery, also called blepharoplasty of the lower eyelid, is a cosmetic procedure that helps correct lose skin, excess fat, and wrinkles of the lower eye area. Excess skin on the lower eyelid causes wrinkles and bulges. Reasons for undergoing an upper blepharoplasty may be purely cosmetic (to reduce the appearance of aging), functional (to reduce obstruction of vision by overhanging skin), or both. Functional upper blepharoplasty involves reduction of the upper eyelid to improve visual obstruction caused by redundant lid tissue.Key factors driving the growth of the blepharoplasty market includes the increase in the prevalence of vision impairment, and rise in the adoption of non-invasive surgical procedures. The increase in the prevalence of vision impairment due to conditions such as dermatochalasis drives the market growth. Dermatochalasis is a condition that causes a decrease in superior visual field (VF) due to the loosening of the upper eyelid skin, which is folded by the atrophy of the elastic tissue. This condition is more prevalent in elderly population. It leads to difficulties in primary sight, reading, and visual functions due to visual field defects. In addition, lower eyelid sagginess, causes the lower lashes to rub against the eye, leading to irritation, redness, and even damage to the cornea. These conditions cause fewer visual sights and more mobility impairment in geriatric population. For instance, according to a case study reported in Journal of Ophthalmology,” in April 2020, 30% of the population aged 65 and older die or become permanently disabled due to falling once a year or more. In addition, as per the same source, every 10% loss in the visual field corresponds to an 8% higher risk of falls in adults older than 65 years. Thus, rise in the prevalence of risk associated with dermatochalasis and indirect increase in mobility impairment in geriatric population due to excessive accumulation of fat in upper eyelid are expected to propel the growth of blepharoplasty market during forecast period. Moreover, the increase in the number of plastic surgeons, and the rise in awareness to improve the appearance of the eyes and make them look more attractive boosts the market growth. For instance, according to the report published by International Society of Aesthetic Plastic Surgery in 2021, a total of 12,840,688 surgical procedures were performed globally in 2021 out of which 1,446,890 eyelids surgeries are performed which is 11.3% of total surgical procedures performed.
The market also offers growth opportunities to the key players in the market. As people age, the skin around the eyes can lose elasticity, leading to wrinkles, bags, and sagging skin. These changes can make a person look older and can also affect their self-confidence. Many people shift toward minimally invasive cosmetic surgeries, in the desire to improve appearance which is expected to create lucrative growth opportunities for the blepharoplasty market. Furthermore, increase in celebrity population and urge to look beautiful irrespective of gender has increased the need for cosmetic surgeries such as rhinoplasty, abdominoplasty, blepharoplasty, and others, which further drives the market growth. For instance, according to the American Society of Plastic Surgeons, in 2020, approximately 85% of blepharoplasty procedures were performed on women, and 15% were performed on men. Overall, the increase in adoption of cosmetic surgery can be seen as an opportunity for blepharoplasty market, as more people become interested in enhancing their appearance and correcting functional problems caused by excess skin and fat around the eyes. For instance, according to International Society of Aesthetic Plastic Surgery report, approximately 12,840,688 cosmetic surgeries were performed in year 2021. Thus, increase in cosmetic surgeries owing to its advantages such as minimally invasive nature, and high success rate creates opportunities which is boost the market growth.
The blepharoplasty market is segmented on the basis of type, gender, service provider, and region. By type, the market is segmented into upper eyelid surgery, lower eyelid surgery and combination eyelid surgery. By gender, it is bifurcated into female and male. By service provider, it is segmented into, hospitals, clinics, and ambulatory surgical centers. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in the blepharoplasty market are Sisram Medical Ltd, AbbVie Inc, LightScalpel , Lumenis, Grand Aespio Inc., Medtronic plc, Surgical Holdings Ltd., Medline industries, inc., London Bridge Plastic Surgery, M A Corporation.
Key Market Insights
By type, the upper eyelid surgery segment is expected to experience rapid growth in the market and is estimated to reach $ 3,437 million by 2031, with a CAGR of 8.2%. However, the lower eyelid surgery segment is estimated to be growing with a significant CAGR of 7.9% during the forecast period.By gender, the female segment dominated the global market. However, the male segment is expected to grow with a significant CAGR of 6.4% during the forecast period.
By service provider, the hospitals segment dominated the global market. However, the clinics segment is expected to grow with a significant CAGR of 7.7% during the forecast period
Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 8.8% during the forecast period.
Companies Mentioned
- Abbvie Inc
- LightScalpel
- Lumenis
- Medtronic plc
- Surgical Holdings Ltd.
- Medline industries, inc.
- Sisram Medical Ltd
- Grand Aespio Inc.
- London Bridge Plastic Surgery
- M A Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 232 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 3454.64 million |
| Forecasted Market Value ( USD | $ 7202.67 million |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
